Smartwatch-Guided prehab aims to boost pancreatic surgery recovery

NCT ID NCT07772258

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether a wearable device and a personalized prehabilitation program can help adults recover better after surgery for pancreatic cancer or related conditions. Participants will wear a monitor to track vital signs and activity, and follow a program of exercise, nutrition, and wellbeing support before and after surgery. The study compares their outcomes to a similar group who received standard care, looking at complications and recovery over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A wearable monitoring device (Corsano CardioWatch) and a personalized prehabilitation and rehabilitation program (Prehab4Cancer) combining exercise, nutrition, and wellbeing support.
What this could lead to
If effective, this approach could reduce complications and speed recovery after pancreatic surgery, potentially improving outcomes for patients.
What could go wrong
The trial is early and compares against historical controls, which may limit reliability. The intervention may not reduce complications, and wearable use could be burdensome for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMPULLARY CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.